Abstract
Lung cancer is the most common neoplastic disease in Eastern and Central Europe. The role of hereditary factors in lung carcinogenesis is not fully understood. Family history (FH) of lung cancer and other tobacco-related cancers might be a strong predictor of the lung cancer risk. We investigated family history of cancer among first-degree relatives of 2,861 patients with lung cancer and 3,118 controls from the Czech Republic, Hungary, Poland, Romania, Russia, Slovakia, and United Kingdom within the IARC Multicenter Case–Control Study. Odds ratios (ORs) and 95% CI were calculated using logistic regression, adjusting for age, gender, study center, education, tobacco smoking, and number of first-degree relatives. In addition, we conducted a meta-analysis of 41 studies on FH of cancer and lung cancer risk. Positive FH of lung cancer increased risk of lung cancer with OR of 1.63 (95%CI: 1.31–2.01), and having two or more affected relatives with lung cancer further increased the risk of lung cancer with OR 3.60 (95%CI: 1.56–8.31). Among subjects aged less than 50, the OR for FH of lung cancer was 2.08 (95%CI: 1.18–3.63). The associations were generally stronger for squamous cell carcinoma and large cell carcinoma subtypes. Heterogeneity in results was not found with respect to smoking status and gender. A significant association was not observed for FH of other smoking-related tumors. The results of meta-analysis were consistent with that of our study with regard to young onset, non-smokers and histology. FH of lung cancer is a predictor of an increased risk of lung cancer, especially in subjects aged less than 50.
Similar content being viewed by others
References
Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P (2009) Cancer incidence in five Continents, vol.IX.IARC Scientific Publications No 160
Peto R, Lopez A, Boreham J, Thun M (2006) Mortality from smoking in developed countries 1950-2000. CTSU, Oxford
Brennan P, Crispo A, Zaridze D et al (2006) High cumulative risk of lung cancer death among smokers and nonsmokers in Central and Eastern Europe. Am J Epidemiol 164:1233–1241
Spitz MR, Hong WK, Amos CI et al (2007) A risk model for prediction of lung cancer. J Natl Cancer Inst 99:715–726
Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer in humans. J Natl Cancer Inst 30:289–312
Matakidou A, Eisen T, Houlston RS (2005) Systematic review of the relationship between family history and lung cancer risk. Br J Cancer 93:825–833
Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE (1999) Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol 17:253–273
Sellers TA, Chen PL, Potter JD, Bailey-Wilson JE, Rothschild H, Elston RC (1994) Segregation analysis of smoking-associated malignancies: evidence for Mendelian inheritance. Am J Med Genet 52:308–314
Amos CI, Wu X, Broderick P et al (2008) Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1. Nat Genet 40:616–622
Hung RJ, McKay JD, Gaborieau V et al (2008) A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25. Nature 452:633–637
Thorgeirsson TE, Geller F, Sulem P et al (2008) A variant associated with nicotine dependence, lung cancer and peripheral arterial disease. Nature 452:638–642
McKay JD, Hung RJ, Gaborieau V et al (2008) Lung cancer susceptibility locus at 5p15.33. Nat Genet 40:1404–1406
Bailey-Wilson JE, Amos CI, Pinney SM et al (2004) A major lung cancer susceptibility locus maps to chromosome 6q23–25. Am J Hum Genet 75:460–474
Xu H, Spitz MR, Amos CI, Shete S (2005) Complex segregation analysis reveals a multigene model for lung cancer. Hum Genet 116:121–127
Liu P, Vikis HG, Wang D et al (2008) Familial aggregation of common sequence variants on 15q24–25.1 in lung cancer. J Natl Cancer Inst 100:1326–1330
Spitz MR, Amos CI, Dong Q, Lin J, Wu X (2008) The CHRNA5–A3 region on chromosome 15q24–25.1 is a risk factor both for nicotine dependence and for lung cancer. J Natl Cancer Inst 100:1552–1556
Wang Y, Broderick P, Matakidou A, Eisen T, Houlston RS (2010) Role of 5p15.33 (TERT-CLPTM1L), 6p21.33 and 15q25.1 (CHRNA5-CHRNA3) variation and lung cancer risk in never-smokers. Carcinogenesis 31:234–238
DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188
Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539–1558
Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629–634
Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088–1101
Macaskill P, Walter SD, Irwig L (2001) A comparison of methods to detect publication bias in meta-analysis. Stat Med 20:641–654
Wu PF, Lee CH, Wang MJ et al (2004) Cancer aggregation and complex segregation analysis of families with female non-smoking lung cancer probands in Taiwan. Eur J Cancer 40:260–266
Liu ZY, He XZ, Chapman RS (1991) Smoking and other risk factors for lung cancer in Xuanwei, China. Int J Epidemiol 20:26–31
Horwitz RI, Smaldone LF, Viscoli CM (1988) An ecogenetic hypothesis for lung cancer in women. Arch Intern Med 148:2609–2612
Wang TJ, Zhou BS, Shi JP (1996) Lung cancer in nonsmoking Chinese women: a case-control study. Lung Cancer 14(1):S93–S98
Tsugane S, Watanabe S, Sugimura H, Arimoto H, Shimosato Y, Suemasu K (1987) Smoking, occupation and family history in lung cancer patients under fifty years of age. Jpn J Clin Oncol 17:309–317
Wang XR, Yu IT, Chiu YL et al (2009) Previous pulmonary disease and family cancer history increase the risk of lung cancer among Hong Kong women. Cancer Causes Control 20:757–763
Osann KE (1991) Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 51:4893–4897
Schwartz AG, Yang P, Swanson GM (1996) Familial risk of lung cancer among nonsmokers and their relatives. Am J Epidemiol 144:554–562
Tokuhata GK, Lilienfeld AM (1963) Familial aggregation of lung cancer among hospital patients. Public Health Rep 78:277–283
Gorlova OY, Zhang Y, Schabath MB et al (2006) Never smokers and lung cancer risk: a case-control study of epidemiological factors. Int J Cancer 118:1798–1804
Wunsch-Filho V, Boffetta P, Colin D, Moncau JE (2002) Familial cancer aggregation and the risk of lung cancer. Sao Paulo Med J 120:38–44
Ooi WL, Elston RC, Chen VW, Bailey-Wilson JE, Rothschild H (1986) Increased familial risk for lung cancer. J Natl Cancer Inst 76:217–222
Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE (1988) Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 48:7279–7284
McDuffie HH (1991) Clustering of cancer in families of patients with primary lung cancer. J Clin Epidemiol 44:69–76
Neuberger JS, Mahnken JD, Mayo MS, Field RW (2006) Risk factors for lung cancer in Iowa women: implications for prevention. Cancer Detect Prev 30:158–167
Kramer A, Graham S, Burnett W, Nasca P (1987) Familial aggregation of lung cancer stratified by smoking. Am J Epidemiol 126:766 (abstract)
Mayne ST, Buenconsejo J, Janerich DT (1999) Familial cancer history and lung cancer risk in United States nonsmoking men and women. Cancer Epidemiol Biomarkers Prev 8:1065–1069
Samet JM, Humble CG, Pathak DR (1986) Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 134:466–470
Cassidy A, Myles JP, Duffy SW, Liloglou T, Field JK (2006) Family history and risk of lung cancer: age-at-diagnosis in cases and first-degree relatives. Br J Cancer 95:1288–1290
Brownson RC, Alavanja MC, Caporaso N, Berger E, Chang JC (1997) Family history of cancer and risk of lung cancer in lifetime non-smokers and long-term ex-smokers. Int J Epidemiol 26:256–263
Wu AH, Fontham ET, Reynolds P et al (1996) Family history of cancer and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 143:535–542
Gao YT, Blot WJ, Zheng W et al (1987) Lung cancer among Chinese women. Int J Cancer 40:604–609
Cote ML, Kardia SL, Wenzlaff AS, Ruckdeschel JC, Schwartz AG (2005) Risk of lung cancer among white and black relatives of individuals with early-onset lung cancer. JAMA 293:3036–3042
Cassidy A, Balsan J, Vesin A et al. (2009) Cancer diagnosis in first-degree relatives and non-small cell lung cancer risk: Results from a multi-centre case-control study in Europe. Eur J Cancer 45(17):3047–3053
Jin YT, Xu YC, Yang RD, Huang CF, Xu CW, He XZ (2005) Familial aggregation of lung cancer in a high incidence area in China. Br J Cancer 92:1321–1325
Etzel CJ, Amos CI, Spitz MR (2003) Risk for smoking-related cancer among relatives of lung cancer patients. Cancer Res 63:8531–8535
Shaw GL, Falk RT, Pickle LW, Mason TJ, Buffler PA (1991) Lung cancer risk associated with cancer in relatives. J Clin Epidemiol 44:429–437
Bromen K, Pohlabeln H, Jahn I, Ahrens W, Jockel KH (2000) Aggregation of lung cancer in families: results from a population-based case-control study in Germany. Am J Epidemiol 152:497–505
Wu-Williams AH, Dai XD, Blot W et al (1990) Lung cancer among women in north-east China. Br J Cancer 62:982–987
Rachtan J, Sokolowski A, Niepsuj S, Zemla B, Zwierko M (2009) Familial lung cancer risk among women in Poland. Lung Cancer 65(2):138–143
Matakidou A, Eisen T, Bridle H, O’Brien M, Mutch R, Houlston RS (2005) Case-control study of familial lung cancer risks in UK women. Int J Cancer 116:445–450
Gao Y, Goldstein AM, Consonni D et al (2009) Family history of cancer and nonmalignant lung diseases as risk factors for lung cancer. Int J Cancer 125:146–152
Kreuzer M, Kreienbrock L, Gerken M et al (1998) Risk factors for lung cancer in young adults. Am J Epidemiol 147:1028–1037
Zhang Y, Shu XO, Gao YT et al (2007) Family history of cancer and risk of lung cancer among nonsmoking Chinese women. Cancer Epidemiol Biomarkers Prev 16:2432–2435
Nitadori J, Inoue M, Iwasaki M et al (2006) Association between lung cancer incidence and family history of lung cancer: data from a large-scale population-based cohort study, the JPHC study. Chest 130:968–975
Poole CA, Byers T, Calle EE, Bondy J, Fain P, Rodriguez C (1999) Influence of a family history of cancer within and across multiple sites on patterns of cancer mortality risk for women. Am J Epidemiol 149:454–462
Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH (1994) Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst 86:1600–1608
Jonsson S, Thorsteinsdottir U, Gudbjartsson DF et al (2004) Familial risk of lung carcinoma in the Icelandic population. JAMA 292:2977–2983
Li X, Hemminki K (2005) Familial multiple primary lung cancers: a population-based analysis from Sweden. Lung Cancer 47:301–307
Khoury MJ, Flanders WD (1995) Bias in using family history as a risk factor in case-control studies of disease. Epidemiology 6:511–519
Bondy ML, Strom SS, Colopy MW, Brown BW, Strong LC (1994) Accuracy of family history of cancer obtained through interviews with relatives of patients with childhood sarcoma. J Clin Epidemiol 47:89–96
Chang ET, Smedby KE, Hjalgrim H, Glimelius B, Adami HO (2006) Reliability of self-reported family history of cancer in a large case-control study of lymphoma. J Natl Cancer Inst 98:61–68
Acknowledgments
Financial support from European Commission (DG-XII), contract no. IC15-CT96-0313 is gratefully acknowledged. The Warsaw part of the study was supported by local grant from The Polish State Committee for Scientific Research, grant no. SPUB-M-COPERNICUS/P-05/DZ-30/99/2000.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Lissowska, J., Foretova, L., Dąbek, J. et al. Family history and lung cancer risk: international multicentre case–control study in Eastern and Central Europe and meta-analyses. Cancer Causes Control 21, 1091–1104 (2010). https://doi.org/10.1007/s10552-010-9537-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10552-010-9537-2